Items where Author is "Abolhasani, M."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 33.

Article

Mahmoudi, A.-R. and Ghods, R. and Madjd, Z. and Abolhasani, M. and Saeednejad Zanjani, L. and Safaei, M. and Balaei Goli, L. and Vafaei, S. and Katouzian, L. and Soltanghoraei, H. and Shekarabi, M. and Zarnani, A.-H. (2021) Expression profiling of RTL1 in human breast cancer tissues and cell lines. Experimental and Molecular Pathology, 121.

Beikzadeh, B. and Angaji, S.A. and Abolhasani, M. (2020) Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population. BMC Medical Genetics, 21 (1).

Saeednejad Zanjani, L. and Madjd, Z. and Axcrona, U. and Abolhasani, M. and Rasti, A. and Asgari, M. and Fodstad, �. and Andersson, Y. (2020) Cytoplasmic expression of B7-H3 and membranous EpCAM expression are associated with higher grade and survival outcomes in patients with clear cell renal cell carcinoma. Annals of Diagnostic Pathology, 46.

Shahin, M. and Saeednejad Zanjani, L. and Abolhasani, M. and Rahbar, M. and Asgari, M. and Madjd, Z. (2020) Low level expression of human telomerase reverse transcriptase predicts cancer-related death and progression in embryonal carcinoma. Journal of Cancer Research and Clinical Oncology, 146 (11). pp. 2753-2775.

Anvari, M.S. and Gharib, A. and Abolhasani, M. and Azari-Yam, A. and Gharalari, F.H. and Safavi, M. and Mirzaie, A.Z. and Vasei, M. (2020) Pre-analytical practices in the molecular diagnostic tests, a concise review. Iranian Journal of Pathology, 16 (1). pp. 1-19.

Kaffash Nayeri, R. and Sadri, M. and Shahrokh, H. and Abolhasani, M. and Khaleghimehr, F. and Zolfi, E. and Yousefzadeh Kandevani, N. and Kashi, A.H. (2020) Small Cell Carcinoma of Bladder; Still A Diagnostic and Therapeutic Challenge: Seven Years of Experience and Follow-up in A Referral Center. Urology journal, 17 (4). pp. 363-369.

Kalantari, E. and Abolhasani, M. and Roudi, R. and Farajollahi, M.M. and Farhad, S. and Madjd, Z. and Askarian-Amiri, S. and Mohsenzadegan, M. (2019) Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer. International Journal of Experimental Pathology, 100 (2). pp. 123-132.

Mansoori, M. and Roudi, R. and Abbasi, A. and Abolhasani, M. and Abdi Rad, I. and Shariftabrizi, A. and Madjd, Z. (2019) High GD2 expression defines breast cancer cells with enhanced invasiveness. Experimental and Molecular Pathology, 109. pp. 25-35.

Saeednejad Zanjani, L. and Madjd, Z. and Abolhasani, M. and Rasti, A. and Shariftabrizi, A. and Mehrazma, M. and Fodstad, �. and Asgari, M. (2019) Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma. Pathology, 51 (1). pp. 21-31.

Saeednejad Zanjani, L. and Madjd, Z. and Abolhasani, M. and Rasti, A. and Shariftabrizi, A. and Mehrazma, M. and Fodstad, �. and Asgari, M. (2019) Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma. Pathology, 51 (1). pp. 21-31.

Shariatifar, H. and Hakhamaneshi, M.-S. and Abolhasani, M. and Ahmadi, F.H. and Roshani, D. and Nikkhoo, B. and Abdi, M. and Ahmadvand, D. (2019) Immunofluorescent labeling of CD20 tumor marker with quantum dots for rapid and quantitative detection of diffuse large B-cell non-Hodgkin's lymphoma. Journal of Cellular Biochemistry, 120 (3). pp. 4564-4572.

Shafiei, S. and Kalantari, E. and Saeednejad Zanjani, L. and Abolhasani, M. and Asadi Lari, M.H. and Madjd, Z. (2019) Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas. Experimental and Molecular Pathology, 108. pp. 164-172.

Aboutaleb, N. and Jamali, H. and Abolhasani, M. and Pazoki Toroudi, H. (2019) Lavender oil (Lavandula angustifolia) attenuates renal ischemia/reperfusion injury in rats through suppression of inflammation, oxidative stress and apoptosis. Biomedicine and Pharmacotherapy, 110. pp. 9-19.

Khorasani, M. and Teimoori-Toolabi, L. and Farivar, T.N. and Asgari, M. and Abolhasani, M. and Shahrokh, H. and Afgar, A. and Kalantari, E. and Peymani, A. and Mahdian, R. (2018) Aberrant expression of miR-141 and nuclear receptor small heterodimer partner in clinical samples of prostate cancer. Cancer Biomarkers, 22 (1). pp. 19-28.

Khorasani, M. and Teimoori-Toolabi, L. and Farivar, T.N. and Asgari, M. and Abolhasani, M. and Shahrokh, H. and Afgar, A. and Kalantari, E. and Peymani, A. and Mahdian, R. (2018) Aberrant expression of miR-141 and nuclear receptor small heterodimer partner in clinical samples of prostate cancer. Cancer Biomarkers, 22 (1). pp. 19-28.

Rasti, A. and Mehrazma, M. and Madjd, Z. and Abolhasani, M. and Saeednejad Zanjani, L. and Asgari, M. (2018) Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas. Scientific Reports, 8 (1).

Rasti, A. and Madjd, Z. and Abolhasani, M. and Mehrazma, M. and Janani, L. and Saeednejad Zanjani, L. and Asgari, M. (2018) Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma. Clinical and Experimental Medicine, 18 (2). pp. 177-190.

Rasti, A. and Madjd, Z. and Abolhasani, M. and Mehrazma, M. and Janani, L. and Saeednejad Zanjani, L. and Asgari, M. (2018) Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma. Clinical and Experimental Medicine, 18 (2). pp. 177-190.

Ostadrahimi, S. and Fayaz, S. and Parvizhamidi, M. and Abedi-Valugerdi, M. and Hassan, M. and Kadivar, M. and Teimoori-Toolabi, L. and Asgari, M. and Shahrokh, H. and Abolhasani, M. and Mahdian, R. and Fard-Esfahani, P. (2018) Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines. Oncology Letters, 15 (5). pp. 8157-8164.

Ostadrahimi, S. and Fayaz, S. and Parvizhamidi, M. and Abedi-Valugerdi, M. and Hassan, M. and Kadivar, M. and Teimoori-Toolabi, L. and Asgari, M. and Shahrokh, H. and Abolhasani, M. and Mahdian, R. and Fard-Esfahani, P. (2018) Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines. Oncology Letters, 15 (5). pp. 8157-8164.

Zanjani, L.S. and Madjd, Z. and Abolhasani, M. and Shariftabrizi, A. and Rasti, A. and Asgari, M. (2018) Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma. Cancer Biomarkers, 21 (4). pp. 821-837.

Zanjani, L.S. and Madjd, Z. and Abolhasani, M. and Shariftabrizi, A. and Rasti, A. and Asgari, M. (2018) Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma. Cancer Biomarkers, 21 (4). pp. 821-837.

Zanjani, L.S. and Madjd, Z. and Abolhasani, M. and Rasti, A. and Fodstad, O. and Andersson, Y. and Asgari, M. (2018) Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma. Biomarkers in Medicine, 12 (1). pp. 45-61.

Zanjani, L.S. and Madjd, Z. and Abolhasani, M. and Rasti, A. and Fodstad, O. and Andersson, Y. and Asgari, M. (2018) Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma. Biomarkers in Medicine, 12 (1). pp. 45-61.

Vasei, M. and Abolhasani, M. and Safavi, M. (2018) Vacuolated Lymphocytes as a Clue for Diagnosis of Lysosomal Storage Disease like GM1 Gangliosidosis. Indian Journal of Hematology and Blood Transfusion. pp. 1-2.

Asgari, M. and Maybodi, M.N. and Abolhasani, M. (2016) Differential diagnosis of urothelial carcinoma in situ from non-neoplastic urothelia: Analysis of CK20, CD44, P53 and Ki67. Medical Journal of the Islamic Republic of Iran, 30 (1).

Abolhasani, M. and Salarinejad, S. and Moslemi, M.K. (2016) Ewing sarcoma/primitive neuroectodermal tumor of the kidney: A report of three cases. International Journal of Surgery Case Reports, 28. pp. 330-334.

Fallahabadi, Z.R. and Noori Daloii, M.R. and Mahdian, R. and Behjati, F. and Shokrgozar, M.A. and Abolhasani, M. and Asgari, M. and Shahrokh, H. (2016) Frequency of PTEN alterations, TMPRSS2-ERG fusion and their association in prostate cancer. Gene, 575 (2). pp. 755-760.

Abolhasani, M. and Salarinejad, S. and Asgari, M. (2015) P53 and MDM2 over-expression and five-year survival of kidney cancer patients undergoing radical nephrectomy - Iranian experience. Asian Pacific Journal of Cancer Prevention, 16 (12). pp. 5043-5047.

Mohsenzadegan, M. and Shekarabi, M. and Madjd, Z. and Asgari, M. and Abolhasani, M. and Tajik, N. and Farajollahi, M.M. (2015) Study of NGEP expression pattern in cancerous tissues provides novel insights into prognostic marker in prostate cancer. Biomarkers in Medicine, 9 (4). pp. 391-401.

Mohsenzadegan, M. and Madjd, Z. and Asgari, M. and Abolhasani, M. and Shekarabi, M. and Taeb, J. and Shariftabrizi, A. (2013) Reduced expression of NGEP is associated with high-grade prostate cancers: A tissue microarray analysis. Cancer Immunology, Immunotherapy, 62 (10). pp. 1609-1618.

Rakhshani, N. and Hormazdi, M. and Abolhasani, M. and Shahzadi, M. (2007) Benign metastasizing leiomyoma of the uterus. Archives of Iranian Medicine, 10 (1). pp. 97-99.

Zare-Mirzaie, A. and Khalili-Alam, K. and Abolhasani, M. (2007) Rehydration of air-dried cervical smears: An alternative to routine wet fixation. Acta Medica Iranica, 45 (5). pp. 365-368.

This list was generated on Mon Sep 20 09:34:54 2021 +0430.